On Yesterday, Adaptive Biotechnologies Corp (NASDAQ: ADPT) shares price traded between $15.14 and $30.48 during the last trading session an upbeat with 10.17% at $29.89. The shares recorded trading volume 881.15K shares as compared to its average volume of 480.57K shares. Over the one year trading period, the stock has a peak price of $55.12 and its down is recorded at $26.63.
Adaptive Biotechnologies Corp (NASDAQ: ADPT) recently stated financial results for the quarter ended June 30, 2019.
Second Quarter 2019 Financial Results
Revenue was $22.1M for the quarter ended June 30, 2019, representing a 91% increase from the second quarter in the previous year. Sequencing revenue was $11.9M for the quarter, representing a 43% increase from the second quarter in the previous year. Development revenue increased to $10.3M for the quarter, representing a 213% increase from the second quarter in the previous year.
Operating expenses were $38.2M for the second quarter of 2019, contrast to $24.9M in the second quarter of the previous year, representing a raise of about 54%.
Net loss was $15.7M in the second quarter of 2019, contrast to $12.5M in the same period in 2018.
Adjusted EBITDA (non-GAAP) was a loss of $10.9M for the second quarter of 2019, contrast to a loss of $9.4M in the second quarter of the previous year.
Cash, cash equivalents and marketable securities was $423.0M as of June 30, 2019. Subsequent to the end of the quarter, on July 1, 2019, Adaptive Biotechnologies completed its initial public offering, raising about $321M of net proceeds, after deducting underwriting discounts and commissions.
